Amit Jolly

Amit Jolly is a prominent figure in the biotech investment industry, currently working at Stealth Companies and formerly associated with Carpe Biosciences, a multibillion-dollar family office.1 Here's an overview of his professional background and experience:

Professional Experience

Current Role:: Amit is currently working at Stealth Companies, where he has been since September 2022.1 In this role, he is focused on building companies for patients, leveraging his extensive experience in the biotech sector.1

Previous Positions::

• Biotech Investor at Carpe Biosciences (February 2021 to September 2022)1
• Research Associate - Biotechnology Equity (January 2021 to February 2021)1
• Life Sciences Strategy Senior Advisor (January 2019 to January 2021)1
• Founder & CEO of a Pharma & Digital Health Consulting firm (January 2017 to January 2019)1
• Senior Healthcare Analyst at GlobalData's Clinical Research Investigative Reporting (January 2016 to January 2017)1
• Healthcare Analyst at GlobalData's Clinical Research Investigative Reporting (January 2013 to January 2015)1

Education

Amit Jolly has attended several prestigious institutions:

• Rutgers, The State University of New Jersey-New Brunswick
• The Peddie School
• Columbia University in the City of New York1

Additional Information

Amit describes himself as an institutional biotech investor on his Twitter profile, where he states, "My name means unlimited happiness and my blood type is Be Positive".2 He is based in Miami, Florida, but also has connections to New York City.12

Professionally, Amit is known for his expertise in biotechnology, healthcare analysis, and investment strategies in the life sciences sector. His diverse experience spans roles in consulting, research, and executive positions within the biotech and pharmaceutical industries.1